Results 81 to 90 of about 263,787 (314)

Therapeutic evaluation of homeopathic treatment for canine oral papillomatosis [PDF]

open access: yes, 2020
Aim: A study was conducted to evaluate the ameliorative potential of homeopathic drugs in combination (Sulfur 30C, Thuja 30C, Graphites 30C, and Psorinum 30C) in 16 dogs affected with oral papillomatosis which was not undergone any previous treatment ...
Kumar, M. Asok   +5 more
core   +2 more sources

Costs of delivering human papillomavirus vaccination in Tanzania [PDF]

open access: gold, 2022
Verena Struckmann   +9 more
openalex   +1 more source

Does Modified 5‐Item Frailty Index Correlate With Survival in Oropharyngeal Squamous Cell Carcinoma?

open access: yesHead &Neck, EarlyView.
ABSTRACT Introduction Oropharyngeal squamous cell cancer (OPSCC) is a common subtype of head and neck cancer. It is generally stratified into high, intermediate, and low risk prognostic groups on the basis of HPV (human papillomavirus) status and smoking history (Ang risk stratification).
Marta Chmielecka   +10 more
wiley   +1 more source

A multimodal approach to improving human papillomavirus vaccination in a community pharmacy setting

open access: yesSAGE Open Medicine, 2016
Background: Community pharmacy has become a major access point for several types of vaccinations. Despite the success of vaccination programs like influenza, pneumococcal, and herpes zoster, the rates of human papillomavirus vaccination continue to lag ...
Kenneth C Hohmeier   +3 more
doaj   +1 more source

Cutaneous HPV16 and p16 Positive Basaloid Squamous Cell Carcinoma with Brain Metastasis: A Case Report

open access: yesSAGE Open Medical Case Reports, 2020
Basaloid squamous cell carcinoma is an infiltrative and aggressive variant of squamous cell carcinoma with basaloid features. Primary skin-derived basaloid squamous cell carcinoma is rare.
Trang T Vu   +4 more
doaj   +1 more source

Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes. [PDF]

open access: yes, 2019
BackgroundHuman papillomaviruses (HPV) cause over 500 000 cervical cancers each year, most of which occur in low-resource settings. Human papillomavirus genotyping is important to study natural history and vaccine efficacy. We evaluated TypeSeq, a novel,
Boland, Joseph   +20 more
core   +1 more source

Safety and Efficacy Findings From a Phase Ib/II Study of ASP‐1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

open access: yesHead &Neck, EarlyView.
ABSTRACT Background ASP‐1929 photoimmunotherapy—cetuximab conjugated to IRDye 700DX and red light (690 nm) for localized drug activation—results in rapid, selective cell killing. Methods This phase Ib/II open‐label study evaluated ASP‐1929 photoimmunotherapy plus pembrolizumab in patients with recurrent/metastatic HNSCC (≥ 1 accessible lesion, PD‐L1 ...
David M. Cognetti   +17 more
wiley   +1 more source

Awareness about Human Papilloma Virus and its vaccine among medical students

open access: yesIndian Journal of Community Medicine, 2013
Background: Cancer of the uterine cervix is the most common malignancy amongst women in India. Identification of its pre-cancerous lesions and prevention by HPV vaccine may go a long way in decreasing the incidence.
Sumita Mehta   +3 more
doaj   +1 more source

Congenital cutaneous fibropapillomatosis in a warmblood foal [PDF]

open access: yes, 2016
In this report, clinical and histological findings of a rare case of a large congenital fibropapilloma on the forehead of a warmblood foal are reported. Surgical excision was curative and no recurrence was observed after nine months.
de Cock, Hilde   +5 more
core   +1 more source

Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction [PDF]

open access: yes, 2019
Examination of cross-protection and type replacement after human papillomavirus (HPV) vaccine introduction is essential to guide vaccination recommendations and policies.
Bernstein, David I.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy